|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/435 | |
| A61K 38/00 |
| (11) | Number of the document | 2393831 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10703194.0 |
| Date of filing the European patent application | 2010-02-04 | |
| (97) | Date of publication of the European application | 2011-12-14 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2010/000213 |
| Date | 2010-02-04 |
| (87) | Number | WO 2010/100396 |
| Date | 2010-09-10 |
| (30) | Number | Date | Country code |
| PCT/GB2009/0003 | 2009-02-05 | WO | |
| 0906779 | 2009-04-20 | GB |
| (72) |
NUNN, Miles, A., GB
LEA, Susan, M., GB
ROVERSI, Pietro, C., GB
|
| (73) |
Volution Immuno Pharmaceuticals SA,
Place Des Eaux Vives 6,, 3461-1211 Geneve 3,
CH
|
| (54) | MODIFIED OMCI AS A COMPLEMENT INHIBITOR |
| MODIFIED OMCI AS A COMPLEMENT INHIBITOR |